PSNL

6.72

1.97% 0.13

Dopo l'orario di chiusura: 6.72

Personalis Inc (PSNL)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$6.59

Aprire:

$6.66

Volume 24 ore:

1.99M

Relative Volume:

1.39

Capitalizzazione di mercato:

$703.13M

Reddito:

$73.48M

Utile/perdita netta:

$-108.30M

Rapporto P/E:

-2.9867

EPS:

-2.25

Flusso di cassa netto:

$-67.17M

1 W Prestazione:

-14.29%

1M Prestazione:

-18.15%

6M Prestazione:

+14.87%

1 anno Prestazione:

+88.24%

Intervallo 1D:

$6.6505

$7.105

Intervallo di 1 settimana:

$6.56

$8.4156

Portata 52W:

$2.8262

$11.50

Personalis Inc Stock (PSNL) Company Profile

Nome

Personalis Inc

Settore

Healthcare (1116)

Industria

Diagnostics & Research (52)

Telefono

650-752-1300

Indirizzo

6600 DUMBARTON CIRCLE, FREMONT, CA

Dipendente

260

Cinguettio

@PersonalisInc

Prossima data di guadagno

2024-11-06

Ultimi documenti SEC

PSNL's Discussions on Twitter

Compare PSNL vs TMO, DHR, IDXX, A, WAT

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
PSNL Personalis Inc	6.72	703.13M	73.48M	-108.30M	-67.17M	-2.25
TMO Thermo Fisher Scientific Inc	464.37	172.51B	44.56B	6.72B	6.29B	17.74
DHR Danaher Corp	187.32	132.46B	24.57B	3.60B	5.26B	5.051
IDXX Idexx Laboratories Inc	573.82	45.69B	4.30B	1.06B	1.04B	13.08
A Agilent Technologies Inc	111.51	31.51B	7.07B	1.29B	993.00M	4.5355
WAT Waters Corp	286.57	28.11B	3.17B	642.63M	516.49M	10.77

Personalis Inc Stock (PSNL) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-12-02	Ripresa	Morgan Stanley	Equal-Weight
2025-05-15	Iniziato	Guggenheim	Buy
2025-03-17	Iniziato	Craig Hallum	Buy
2023-02-06	Aggiornamento	Needham	Hold → Buy
2022-01-07	Aggiornamento	BofA Securities	Neutral → Buy
2021-11-05	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2021-11-03	Downgrade	Needham	Buy → Hold
2021-10-15	Ripresa	Cowen	Outperform
2021-09-20	Reiterato	Needham	Buy
2021-05-06	Aggiornamento	Oppenheimer	Perform → Outperform
2021-01-28	Iniziato	Truist	Buy
2021-01-04	Downgrade	BofA Securities	Buy → Neutral
2020-11-12	Reiterato	Needham	Buy
2020-11-06	Downgrade	Oppenheimer	Outperform → Perform
2020-10-19	Iniziato	Citigroup	Buy
2020-10-08	Iniziato	BTIG Research	Buy
2020-08-27	Iniziato	H.C. Wainwright	Buy
2020-08-18	Iniziato	Needham	Buy
2019-09-26	Aggiornamento	BofA/Merrill	Neutral → Buy
2019-07-15	Iniziato	BofA/Merrill	Neutral
2019-07-15	Iniziato	Cowen	Outperform
2019-07-15	Iniziato	Morgan Stanley	Overweight
2019-07-15	Iniziato	Oppenheimer	Outperform

Mostra tutto

Personalis Inc Borsa (PSNL) Ultime notizie

Mar 12, 2026

Personalis Announces New Publication Advancing Neoadjuvant Treatment Monitoring in Breast Cancer with NeXT Personal - BioSpace

Mar 12, 2026

Personalis (PSNL) Publishes Promising Study on Cancer Detection Method - GuruFocus

Mar 12, 2026

Personalis Announces New Publication Advancing Neoadjuvant Treatment Monitoring in Breast Cancer with NeXT Personal® - Business Wire

Mar 12, 2026

Mar 11, 2026

Personalis, Inc. (NASDAQ:PSNL) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Mar 11, 2026

Mar 10, 2026

Growth Report: Is Personalis Inc showing insider buyingEarnings Growth Report & Consistent Profit Trade Alerts - baoquankhu1.vn

Mar 10, 2026

Mar 08, 2026

Personalis (NASDAQ:PSNL) Rating Increased to Hold at Wall Street Zen - MarketBeat

Mar 08, 2026

Mar 06, 2026

Momentum Shift: Is Personalis Inc benefiting from interest rate changesJuly 2025 Earnings & Short-Term Trading Opportunity Alerts - baoquankhu1.vn

Mar 06, 2026

Is Personalis Inc. stock attractive after correctionTrade Risk Summary & Weekly High Momentum Picks - Naître et grandir

Mar 06, 2026

Personalis Stock Pre-Market (-5.3%): FY26 Guidance Overshadows Q4 EPS Beat - Trefis

Mar 06, 2026

Mar 05, 2026

Morgan Stanley Has Lowered Expectations for Personalis (NASDAQ:PSNL) Stock Price - MarketBeat

Mar 05, 2026

PSNL: Morgan Stanley Maintains Equal-Weight, Lowers Price Target - GuruFocus

Mar 05, 2026